Drug Type mRNA |
Synonyms hPBGD mRNA Moderna Therapeutics, hPBGD mRNA(Moderna) |
Target |
Action modulators |
Mechanism PBGD modulators(Porphobilinogen deaminase modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Porphyria, Acute Intermittent | Preclinical | United States | 04 Oct 2024 | |
| Porphyria, Acute Intermittent | Preclinical | Spain | 04 Oct 2024 |





